About CTI Molecular Imaging
CTI Molecular Imaging is a company based in Knoxville (United States) founded in 1983 was acquired by Siemens in March 2005.. CTI Molecular Imaging offers products and services including PET Scan and PET/CT Scan. CTI Molecular Imaging operates in a competitive market with competitors including ImaginAb, AC Immune, APRINOIA, Innovate Biopharma and Progenics, among others.
- Headquarter Knoxville, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CTI Molecular Imaging
CTI Molecular Imaging offers a comprehensive portfolio of products and services, including PET Scan and PET/CT Scan. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive technique to detect cellular function in cancer and other diseases.
Integrates PET and CT for detailed anatomical and functional disease analysis.
Funding Insights of CTI Molecular Imaging
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CTI Molecular Imaging
CTI Molecular Imaging has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Siemens. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Industrial software is developed for automation, electrification, and digitalization solutions.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CTI Molecular Imaging
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CTI Molecular Imaging
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cti Molecular Imaging Comparisons
Competitors of CTI Molecular Imaging
CTI Molecular Imaging operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImaginAb, AC Immune, APRINOIA, Innovate Biopharma and Progenics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| domain | founded_year | HQ Location |
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
|
|
| domain | founded_year | HQ Location |
Diagnostics and therapeutics for neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs and imaging agent for GI disorders
|
|
| domain | founded_year | HQ Location |
Imaging compounds & targeted radiotherapies to detect and treat prostate cancer.
|
|
| domain | founded_year | HQ Location |
Radioactive molecular imaging agents for cancer are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about CTI Molecular Imaging
When was CTI Molecular Imaging founded?
CTI Molecular Imaging was founded in 1983.
Where is CTI Molecular Imaging located?
CTI Molecular Imaging is headquartered in Knoxville, United States. It is registered at Knoxville, Tennessee, United States.
What does CTI Molecular Imaging do?
CTI Molecular Imaging provides products and services for positron emission tomography (PET), a diagnostic imaging technology used in the detection and treatment of cancer, cardiac disease and neurological disorders. It also later extended its business into research, development and the distribution of PET tracers and probes. In 2004, CTC acquired ImTek, a provider of micro-CT systems for imaging laboratory animals used in medical research. On March 18th, 2005 Siemens acquired CTI for about 1 billion and is now operating as its subsidiary with the name Siemens Molecular Imaging.
Who are the top competitors of CTI Molecular Imaging?
What products or services does CTI Molecular Imaging offer?
CTI Molecular Imaging offers PET Scan and PET/CT Scan.
Who are CTI Molecular Imaging's investors?
CTI Molecular Imaging has 1 investor. Key investors include Siemens.